Quantcast

Latest pharmaceutical industry Stories

2014-09-18 12:30:02

Liz Moench, President & CEO of MediciGroup® Inc., will Chair the Allan Lloyds Patient Recruitment and Retention Summit Asia-Emerging Markets, 2014 PHILADELPHIA and LONDON, Sept. 18, 2014 /PRNewswire/ -- It's a new era for biopharmaceutical companies. Competition for innovation, increasing clinical development costs, new technologies and a necessity to keep up with the fast-changing environment are important factors driving industry change. These factors also influence clinical trials, and...

2014-09-18 12:29:37

DARMSTADT, Germany, September 18, 2014 /PRNewswire/ -- - Stefan Oschmann appointed Deputy CEO and Vice Chairman of the Executive Board - Belen Garijo appointed new member of the Executive Board - Changes effective from January 1, 2015 Merck KGaA today announced that the Board of Partners has promoted Stefan Oschmann (57) to the position of Deputy CEO and Vice Chairman of the Executive Board. Concurrently, Belen Garijo (54) was...

2014-09-18 12:29:26

PLYMOUTH MEETING, Pa., Sept. 18, 2014 /PRNewswire/ -- ePharmaSolutions, the leading provider of eClinical trial solutions, was recognized as the Disruptive Innovator of the Year at Dpharm 2014 for its ePharmaONE cloud-based eClinical platform. This solution includes an integrated clinical trial portal and electronic trial master file (eTMF), a remote monitoring application, eSource and electronic informed-consent solution, and ePharmaSolutions' ReferralPlus+ patient screening and...

2014-09-18 12:26:07

LONDON, September 18, 2014 /PRNewswire/ -- Pharma IQ, after huge demand from their audience, has updated the incredibly successful Serialisation Countdown calendar to cover the years 2014 - 2018 inclusive. The interactive PDF, available at pharmaserialisation.com [http://www.pharmaserialisation.com/redForms.aspx?eventid=8856&id=389080&FormID=%2011&frmType=Additional%20Content&m=22825&FrmBypass=False&mLoc=F&SponsorOpt=False&mac=PMIQ_PR ] shows...

2014-09-18 08:30:35

MOUNTAIN VIEW, Calif., Sept.18, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on the commercial activities related to ADASUVE(®) inhalation powder, pre-dispensed (Staccato(®) loxapine) in the European Union (EU). Grupo Ferrer Internacional, S.A. (Ferrer) is Alexza's commercial partner for ADASUVE in the European Union, Latin America and the CIS countries (the Ferrer Territory). Ferrer has distribution agreements with AOP Orphan Pharmaceuticals...

2014-09-18 08:30:07

DUBLIN and MELBOURNE, Australia, Sept. 18, 2014 /PRNewswire/ -- Veterinary biologic therapy developer Nexvet Biopharma today announced the appointments of Dr. Ashraf Hanna, M.D., Ph.D., and Dr. Joseph McCracken D.V.M., M.S., to its Board of Directors. Dr. Hanna is the Vice President of Commercial and Medical Affairs Finance at Genentech and Chief Financial Officer for the Genentech Foundation, while Dr. McCracken most recently served as Vice President and Global Head of Business...

2014-09-18 08:29:10

Drug Development Team Now Complete and Fully Focused on Clinical Trial Implementation NEW YORK, Sept. 18, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has appointed Mr. Christopher W. James to the position of Senior Director of Clinical Development. During his extensive career in Clinical Research, Mr. James has established and led successful global...

2014-09-18 08:28:42

OTTAWA, Sept. 18, 2014 /CNW/ - A new expert panel report, Improving Medicines for Children in Canada, released today by the Council of Canadian Academies, addresses the importance of developing safe and effective medicines for children. Each year about half of Canada's seven million children use at least one prescription drug. Much of this prescribing is done off-label (i.e. the prescription differs from the authorized use), creating potential health risks. Children have historically been...

2014-09-18 08:20:30

PLYMOUTH MEETING, Pa., Sept. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today CEO Dr. J. Joseph Kim will be presenting at two upcoming investor conferences in New York, NY: Biocentury's NewsMakers in the Biotech Industry Conference and Bernstein's Genes as Drugs Event. NewsMakers in the Biotech IndustrySeptember 26, 20142:30 PM ETInvestor Presentation Bernstein's Genes as DrugsOctober 7, 20141:00 PM ETThis presentation will not be webcasted....

2014-09-17 23:03:16

In-demand research report “2014 World In Vitro Diagnostics Industry: Market Shares and Country Forecasts for 400 Assays, 20 Market Segments and 14 Test Locations--Emerging Opportunities and Business Expansion Strategies for Suppliers” worked out by Venture Planning Group (VPG) is now available at MarketPublishers.com. London, UK (PRWEB) September 17, 2014 The in vitro diagnostics (IVD) marketplace is a subset of the total medical technology market, focusing on molecular diagnostics...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'